Trials / Completed
CompletedNCT05279482
Comparison Between Different Doses of Steroids in COVID-19 Patients
Comparison Between Standard Dose Methyl Prednisolone and Megadose Methyl Prednisolone as Regards Outcome in SARS.COV.2 Patients in Intensive Care Unit : Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 104 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
aim of this study is to compare between standard dose methyl prednisolone and mega dose methyl prednisolone as regards outcome reflected by mortality rate, percentage of mechanically ventilated patients and icu length of stay of covid 19 patients admitted in intensive care unit.
Detailed description
Retrospective study for comparison between standard dose methyl prednisolone and mega dose methyl prednisolone as regards outcome reflected by mortality rate ,percentage of mechanically ventilated patients and icu length of stay of covid 19 patients admitted in intensive care unit. Previous studies suggested that cytokine release syndrome could be involved in the pathophysiology of critical SARS.COV.2 resulting in death so early suppression of cytokine storm may be lifesaving in critical patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | observation for outcome of methylprednisolone dose | no intervention as it is retrospective study for outcome |
Timeline
- Start date
- 2022-01-19
- Primary completion
- 2022-03-01
- Completion
- 2022-03-09
- First posted
- 2022-03-15
- Last updated
- 2022-03-15
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05279482. Inclusion in this directory is not an endorsement.